VCYT's Afirma and Decipher fuel strong test volume growth and a debt-free balance sheet, but rising macro costs and expenses temper the outlook.

This collaboration has broad implications for biopharma and precision medicine. Researchers will be able to generate causal data, clinicians will be able to access new functional maps for interpreting ...

The growing evidence that inflammation is a primary cause of aging skin supports ongoing efforts to study targeted ...

Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...

A research team compared cassava—naturally adapted to tropical climates—with heat-sensitive potato to understand how each ...

For years, orange juice has been sold as a simple source of vitamin C, but new human data suggest that a morning glass may be ...

Aquatic plants are specialized evolutionary groups adapted to life in water. They play critical roles as food and medicinal ...

Today at the San Antonio Breast Cancer Symposium (SABCS), researchers presented the initial findings from a major multi-year collaboration between the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and ...

Caris Life Sciences Inc. (NASDAQ:CAI) is one of the best biotech stocks to buy according to Wall Street analysts.

Tanshinones are major bioactive components in Salvia miltiorrhiza and are widely used in cardiovascular therapies. However, ...

The inaugural competition surprisingly awarded two $100,000 grand prizes to address challenges in defining robust benchmarks for complex biology.